OUR SOLUTIONS / MVO (TIGERTRIEVER™ 13)

The only device designed for distals

TIGERTRIEVER™ 13 goes further in the brain to be tough on clots and gentle on the vessels.



OUR SOLUTIONS / MVO (TIGERTRIEVER™ 13)

The only device designed for distals

TIGERTRIEVER™ 13 goes further in the brain to be tough on clots and gentle on the vessels.



Strokes in smaller arteries can still cause disabling deficits, and clot-dissolving drugs work less than half the time.1,2,3


Yet, these vessels are at increased risk for hemorrhage during treatment.

Protect the vessel with TIGERTRIEVER™ 13

Most complications occur during retrieval, as tension can cause vessel stretching, pain, and injury.

TIGERTRIEVER™ is the only device that can remove force before and during retrieval to reduce the potential for injury. 

The comfort

of control

Traditional 3 mm stent retrievers exert higher forces as vessels narrow. Active thrombectomy with TIGERTRIEVER™ 13 adjusts to meet the constraints of the anatomy.

Adjust to the anatomy with TIGER 13. 

Deliver and retrieve with the lowest forces4, 5

The comfort

of control

Traditional 3 mm stent retrievers exert higher forces as vessels narrow. Active thrombectomy with TIGERTRIEVER™ 13 adjusts to meet the constraints of the anatomy.

Adjust to the anatomy with TIGER 13. 

Deliver and retrieve with the lowest forces4,5

Go the distals

Simplify distal reach and tortuous paths with 30% lower delivery profile & delivery force than other 3 mm retrievers.4

Go the distals

Simplify distal reach and tortuous paths with 30% lower delivery profile & delivery force than other3 mm retrievers.4

ADVANCING THE FIELD OF STROKE


Rapid Medical™ is pioneering a new frontier to offer treatment to patients suffering from medium vessel strokes. In addition to engineering devices to the unique requirements of the anatomy, the company is leading scientific advancement with the first-ever FDA-approved study for distal indication, the DISTALS Study. 


Together with clinicians, the company is expanding what’s possible for the medical field and patients who suffer from this debilitating disease. 

Click on a tab below to learn more.

Clinical evidence

PRODUCT OVERVIEW

The world’s first and only adjustable stent retriever, TIGERTRIEVER TM is designed with active, responsive technology for patient-specific procedures.

SPECIFICATIONS

Place an order Ask a product question Request an IFU

How It Works

1 PENETRATE the clot with active integration

2 ADJUST with complete visibility

3 RELAX to relieve vessel traction

Place an order Ask a product question Request an IFU
DR. ALEX SOLICH | Stockholm, Sweden | TIGERTRIEVER™ 13
First-pass distal revascularization with active thrombectomy
View case report →
DR. MICHAEL DIEPERS | Arau, Switzerland | TIGERTRIEVER™ 13
First-pass, TICI 3 reperfusion in an M3 occlusion
View case report →
DR. RAN BRAUNER | Tel Aviv, Israel | TIGERTRIEVER™ 13
First-pass recanalization in a distal M2 occlusion
View case report →
Place an order Ask a product question Request an IFU
×
×
×

1. Waqas M, Kuo CC, Dossani RH, et al. Mechanical thrombectomy versus intravenous thrombolysis for distal large-vessel occlusion: a systematic review and meta-analysis of observational studies. Neurosurg Focus. 2021;51(1):E5. doi:10.3171/2021.4.FOCUS21139

2. Ospel JM, Menon BK, Demchuk AM, et al. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment. Stroke. 2020;51(11):3232-3240. doi:10.1161/STROKEAHA.120.030227

3. Seners P, Turc G, Maier B, Mas JL, Oppenheim C, Baron JC. Incidence and predictors of early recanalization after intravenous thrombolysis: a systematic review and meta‐analysis. Stroke. 2016;47:2409‐2412.

4-5 Data on file

6. Wang, Maud, et al. "The Anch'Or Harpoon Technique With a Manually Expandable Stentretriever (Tigertriever 13), a Technical Note." Frontiers in Neurology, vol. 13, 2022, p. 934690, https://doi.org/10.3389/fneur.2022.934690